Leaflet LERIDIP 20mg film-coated tablets
Indicated for: hypertension
Route of administration: oral
Substance: lercanidipine (calcium channel blocker)
ATC: C08CA13 (Cardiovascular system | Selective calcium channel blockers with mainly vascular effects | Dihydropyridine derivatives)
Lercanidipine is a medication used for the treatment of high blood pressure (hypertension). It belongs to the class of calcium channel blockers in the dihydropyridine group and works by relaxing blood vessels, which reduces vascular resistance and lowers blood pressure.
Lercanidipine is taken orally, usually once daily, preferably at least 15 minutes before a meal, as fatty foods can affect its absorption. It is well-tolerated and has a long-lasting effect, making it suitable for long-term blood pressure control.
Common side effects include headache, dizziness, facial flushing, palpitations, or peripheral edema (swelling of the ankles). Rarely, allergic reactions or severe hypotension may occur. It is important to take lercanidipine as prescribed by a healthcare provider, and alcohol and grapefruit juice should be avoided, as they can enhance the effects of the medication.
General data about LERIDIP 20mg
- Substance: lercanidipine
- Date of last drug list: 01-05-2026
- Commercial code: W43062014
- Concentration: 20mg
- Pharmaceutical form: film-coated tablets
- Quantity: 60
- Product type: original
- Price: 72.94 RON
- Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.
Concentrations available for lercanidipine
- 10mg
- 20mg
Combinations with other substances
Compensation lists for LERIDIP 20mg Berlin Chemie
B - Sublist B with 50% discount from the reference price
Price
Copayment
Patient
72.94 RON
32.44 RON
40.50 RON